From the Guidelines
Zoquezna is not a recognized medical term, and therefore, it is not possible to provide a medical recommendation or guidance on its use. However, based on the provided evidence, it appears that the question may be related to the treatment of insomnia.
Treatment of Insomnia
- The American Academy of Sleep Medicine recommends the use of eszopiclone, zaleplon, and zolpidem as treatment options for sleep onset and maintenance insomnia in adults 1.
- The FDA has warned about the potential risks of benzodiazepine receptor agonists, including sleepwalking, eating, driving, and sexual behavior, and recommends caution when using these medications 1.
- A study published in the Journal of Clinical Sleep Medicine found that suvorexant, an orexin receptor antagonist, was effective in improving sleep onset and maintenance in adults with insomnia, but noted the potential risks of cognitive and behavioral changes, including amnesia, anxiety, and hallucinations 1.
- Another study published in the Annals of Internal Medicine found that zolpidem was effective in reducing sleep onset latency and improving sleep quality, but noted the potential risks of adverse effects, including psychiatric adverse events and memory and driving impairment 1.
Key Considerations
- When treating insomnia, it is essential to consider the potential risks and benefits of each medication and to monitor patients closely for adverse effects.
- The use of benzodiazepines and non-benzodiazepine hypnotics should be approached with caution, and patients should be advised of the potential risks of dependence and withdrawal symptoms.
- Alternative treatment options, such as cognitive-behavioral therapy for insomnia, should be considered before initiating pharmacologic treatment.
- Patients should be educated on the importance of proper sleep hygiene and the potential risks of medication use, including the risk of complex behaviors, such as sleep driving. In conclusion, the treatment of insomnia should be individualized, and patients should be closely monitored for adverse effects, with a focus on minimizing the risk of morbidity, mortality, and improving quality of life 1.
From the Research
Relevant Studies
There are no research papers to assist in answering the question about Zoquezna, as none of the provided studies mention this term.
Available Information
- The provided studies cover various topics, including:
- Vonoprazan vs. proton pump inhibitors for treating gastric and/or duodenal ulcers 2
- Uncertainty during the Brazilian Zika crisis 3
- Antihypertensive medication timing and cardiovascular events 4
- COVID-19 deaths and vaccination coverage 5
- Non-invasive biopsy diagnosis of diabetic kidney disease via deep learning applied to retinal images 6
- None of these studies provide information about Zoquezna.